Brent Hatzis-Schoch, See Remarks at Black Diamond Therapeutics, Inc. (BDTX), sold 6,644 shares at $27.90 ($183K) on 2021-05-12, disclosed to the SEC on 2021-05-13.
Open-market sale of $183k BDTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.11 | 1,161 | $30K | 16.5% |
| 2 | $27.90 | 2,566 | $72K | 39.0% |
| 3 | $27.90 | 2,566 | $72K | 39.0% |
| 4 | $28.20 | 351 | $10K | 5.4% |
| Total | $27.60 avg | 6,644 | $183K | 100% |
| Filing → |
| BDTX | SELL | 2021-02-12 | $214K | — | Filing → |
| BDTX | SELL | 2021-01-14 | $506K | — | Filing → |
| BDTX | SELL | 2020-12-16 | $285K | — | Filing → |